The impact of rosacea on quality of life: Effects of demographic and clinical characteristics and various treatment modalities

British Journal of Dermatology

Volumn 163, Issue 4, 2010, Pages 719-725

  Aksoy, B ^a,b   Altaykan Hapa, A ^c,d   Egemen, D ^e   Karagoz F ^e   Atakan, N ^d  

^a ANKARA NUMUNE HOSPITAL   (Turkey)

^b Private Konak Hospital   (Turkey)

^c Bolu Izzet Baysal State Hospital   (Turkey)

^d HACETTEPE UNIVERSITY   (Turkey)

^e MIDDLE EAST TECHNICAL UNIVERSITY   (Turkey)

Author keywords

clinical study; Dermatology Life Quality Index; quality of life; rosacea; treatment

Indexed keywords

ANTIBIOTIC AGENT; AZITHROMYCIN; DOXYCYCLINE; ISOTRETINOIN; METRONIDAZOLE; STEROID; TETRACYCLINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ASSESSMENT; DEMOGRAPHY; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; ROSACEA; SELF EVALUATION; TREATMENT RESPONSE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; DERMATOLOGIC AGENTS; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; MALE; MIDDLE AGED; PSYCHOMETRICS; QUALITY OF LIFE; ROSACEA; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77957027439     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2010.09894.x     Document Type: Article

References (19)

1. Scheinfeld NS. Rosacea. Skinmed 2006 5 : 191 194.
2. Baldwin HE. Systemic therapy for rosacea. Skin Therapy Lett 2007 12 : 1 5.
3. Wolf JE, del Rosso JQ. The CLEAR trial: results of a large community-based study of metronidazole gel in rosacea. Cutis 2007 79 : 73 80.
4. Öztürkcan S, Ermertcan AT, Eser E, Şahin MT. Cross validation of the Turkish version of Dermatology Life Quality Index. Int J Dermatol 2006 45 : 1300 1307.
5. Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI) - a simple practical measure for routine clinical use. Clin Exp Dermatol 1994 19 : 210 216.
6. Lewis V, Finlay AY. 10 years experience of the Dermatology Life Quality Index (DLQI). J Investig Dermatol Symp Proc 2004 9 : 169 180.
7. Izikson L, English JC, Zirwas MJ. The flushing patient: differential diagnosis, workup and treatment. J Am Acad Dermatol 2006 55 : 193 208.
8. Crawford GH, Pelle MT, James WD. Rosacea: I. Etiology, pathogenesis, and subtype classification. J Am Acad Dermatol 2004 51 : 327 341.
9. Weissenbacher S, Merkl J, Hildebrandt B et al. Pimecrolimus cream 1% for papulopustular rosacea: a randomized vehicle-controlled double-blind trial. Br J Dermatol 2007 156 : 728 732.
10. Wollenberg A, Oppel T. Scoring of skin lesions with the perioral dermatitis severity index (PODSI). Acta Derm Venereol (Stockh) 2006 86 : 251 252.
11. Tan SR, Tope WD. Pulsed dye laser treatment of rosacea improves erythema, symptomatology, and quality of life. J Am Acad Dermatol 2004 51 : 592 593.
12. Menezes N, Moreira A, Mota G, Baptista A. Quality of life and rosacea: pulsed dye laser impact. J Cosmet Laser Ther 2009 11 : 139 141.
13. Sowinska-Glugiewicz I, Ratajczak-Stefanska V, Maleszka R. Role of psychological factors in course of the rosacea. Rocz Akad Med Bialymst 2005 50 (Suppl. 1 49 53.
14. Salamon M, Chodkiewicz J, Sysa-Jedrzejowska A, Wozniacka A. Quality of life in patients with rosacea. Przegl Lek 2008 65 : 385 389.
15. Nicholson K, Abramova L, Chren M-M et al. A pilot quality-of-life instrument for acne rosacea. J Am Acad Dermatol 2007 57 : 213 221.
16. Fleischer A, Chen S. The face and mind evaluation study: an examination of the efficacy of rosacea treatment using physician ratings and patients' self-reported quality of life. J Drugs Dermatol 2005 4 : 585 590.
17. Pelle MT, Crawford GH, James WD. Rosacea: II. Therapy. J Am Acad Dermatol 2004 51 : 499 512.
18. Elewski BE, Fleischer AB, Pariser DM. A comparison of 15% azelaic acid gel and 0.75% metronidazole gel in the topical treatment of papulopustular rosacea: results of a randomized trial. Arch Dermatol 2003 139 : 1444 1450.
19. Gollnick H, Blume-Peytavi U, Szabó EL et al. Systemic isotretinoin in the treatment of rosacea - doxycycline- and placebo-controlled, randomized clinical study. J Dtsch Dermatol Ges 2010 8 : 504 514.